Literature DB >> 30048254

Cholera: recent updates.

Ana A Weil1,2, Edward T Ryan1,2,3.   

Abstract

PURPOSE OF REVIEW: In this review, we will examine updates in cholera epidemiology, advances in our understanding of pathogenesis and protective immunity, and changes to prevention strategies. RECENT
FINDINGS: New modeling techniques and molecular epidemiology have led to advancements in our understanding of how Vibrio cholerae has persisted and re-emerged in new areas during the seventh pandemic. Use of next-generation sequencing has shed new light on immune responses to disease and vaccination, and the role of the gut microbiome in cholera. Increased efficacy and availability of vaccines have made long-term goals of global control of cholera more achievable.
SUMMARY: Advancements in our understanding of immunity and susceptibility to V. cholerae, in addition to an increased global commitment to disease prevention, have led to optimism for the future of cholera prevention.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30048254     DOI: 10.1097/QCO.0000000000000474

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  9 in total

1.  Case Report: Vibrio cholerae Biliary Tract Infections in Two North Africans in France.

Authors:  Philippe Parola; Hussein Anani; Carole Eldin; Gregory Dubourg; Jean-Christophe Lagier; Anthony Levasseur; Jean-Paul Casalta; Didier Raoult; Pierre-Edouard Fournier
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

2.  CitAB Two-Component System-Regulated Citrate Utilization Contributes to Vibrio cholerae Competitiveness with the Gut Microbiota.

Authors:  Ming Liu; Guijuan Hao; Zhe Li; Yitian Zhou; Reyna Garcia-Sillas; Jie Li; Hui Wang; Biao Kan; Jun Zhu
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 3.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

4.  The Type II Secretory System Mediates Phage Infection in Vibrio cholerae.

Authors:  Huihui Sun; Ming Liu; Fenxia Fan; Zhe Li; Yufeng Fan; Jingyun Zhang; Yuanming Huang; Zhenpeng Li; Jie Li; Jialiang Xu; Biao Kan
Journal:  Front Cell Infect Microbiol       Date:  2021-04-16       Impact factor: 5.293

5.  4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae.

Authors:  Francesca Mancuso; Laura De Luca; Federica Bucolo; Milan Vrabel; Andrea Angeli; Clemente Capasso; Claudiu T Supuran; Rosaria Gitto
Journal:  ChemMedChem       Date:  2021-10-18       Impact factor: 3.540

Review 6.  Combating Cholera.

Authors:  Brian Y Hsueh; Christopher M Waters
Journal:  F1000Res       Date:  2019-04-30

7.  Acquisition of Cholera Within the United States.

Authors:  Ganesh Maniam; Emily N Nguyen; John Scott Milton
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

8.  Impact of a human gut microbe on Vibrio cholerae host colonization through biofilm enhancement.

Authors:  Kelsey Barrasso; Denise Chac; Meti D Debela; Catherine Geigel; Anjali Steenhaut; Abigail Rivera Seda; Chelsea N Dunmire; Jason B Harris; Regina C Larocque; Firas S Midani; Firdausi Qadri; Jing Yan; Ana A Weil; Wai-Leung Ng
Journal:  Elife       Date:  2022-03-28       Impact factor: 8.713

9.  A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients.

Authors:  Inès Levade; Ashraful I Khan; Fahima Chowdhury; Stephen B Calderwood; Edward T Ryan; Jason B Harris; Regina C LaRocque; Taufiqur R Bhuiyan; Firdausi Qadri; Ana A Weil; B Jesse Shapiro
Journal:  mSystems       Date:  2021-08-24       Impact factor: 6.496

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.